Mesoblast Ltd - ADR

NASDAQ:MESO   4:00:00 PM EDT
15.07
-0.53 (-3.40%)
6:51:25 PM EDT: $14.91 -0.16 (-1.06%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.93B
Current PEN/A
Forward PE N/A
2yr Forward PE 79.32
See more stats
Estimates Current Quarter
Revenue$16.36 Million
Adjusted EPS-$0.10
See more estimates
10-Day MA$15.07
50-Day MA$14.79
200-Day MA$13.96
See more pivots

Mesoblast Ltd - ADR Stock, NASDAQ:MESO

55 Collins Street, Level 38, Melbourne, Victoria (VIC) 3000
Australia
Phone: +61.3.9639.6036
Number of Employees: 73
http://www.mesoblast.com

Description

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.